Medical Equipment News
Medical Equipment news continually updated from thousands of sources around the net.
2 hrs ago | Seeking Alpha
With the injunction preventing Medtronic from selling its CoreValve System taking effect in just a few days on April 23, the company asks the U.S. Court of Appeals to postpone the order until the firm can determine if the injunction was properly issued.
Trending on the Topix Network
9 hrs ago | Chattanoogan.com
It's becoming more and more difficult to find a "Made in U.S.A." pocket knife these days.
19 hrs ago | Newswise
APRIL 17, 2014-The Kaluza Prizes to honor the best in graduate student bioscience research are growing.
A patent dispute between Medtronic and Edwards Lifesciences over a potentially lifesaving artificial heart valve is prompting a scramble among doctors and hospitals to treat desperately ill elderly patients before a court injunction curtails sale of one of the devices.
For J&J, the new facility is its biggest single investment in a plant and its largest production facility .
"Flynt Publications" has been replaced by "LFP" atop the office building at the corner of Wilshire and La Cienega boulevards in Los Angeles.
Exactech is set to post its Q114 quarterly earnings results on Monday, April 21st.
To celebrate the launch of its Film Noir Edition capsule collection, Luxottica held an event in Milan on Feb. 20 at the city's iconic Biblioteca Ambrosiana.
Nearly three-quarters of consumers consistently recycle in the home, but only about half do so in rooms beyond the kitchen.
Reported by Annette Kreuger, Industrial Info Resources -- It was a definite win for Georgia's burgeoning bioscience sector when Baxter International Corporation decided to invest $1 billion to construct a 1 million-square-foot plasma fractionation facility with purification and fill/finish suites in Covington, Georgia.
Baxter International Inc. today reported first quarter financial results that exceeded the company's previously issued guidance and confirmed its full-year 2014 financial outlook.
's stock had its "sell" rating restated by research analysts at Canaccord Genuity in a report released on Thursday, Stock Ratings News reports.
Positive results have been reported from a phase III clinical trial evaluating the safety, efficacy, and pharmacokinetics of BAX 111 , a recombinant von Willebrand factor under investigation for the treatment of bleeding episodes in patients with von Willebrand disease, the most common type of inherited bleeding disorder.
The FDA reporting system shows over 10,000 deaths and injuries were reported as "adverse events" that may be linked to the company's medical device.
While shares of ICU Medical are down more than -10% so far this year, the stock could very well remain under pressure until its earnings momentum improves.
Several smartphone apps are available to help patients take their medications as prescribed.